RAPT Therapeutics, Inc. (RAPT) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | -100% | -100% | -100% |
| Cost of Goods Sold | 0 | 200K | 0 | 0 | 0 | 0 | 314K | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | -200K | 0 | 0 | 0 | 0 | -314K | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | 100% | - | - | - | - | - | - | -100% | -100% | -100% |
| Operating Expenses | 19.37M | 19.34M | 19.27M | 54.47M | 19.79M | 29.33M | 32.2M | 33.22M | 33.92M | 28.36M | 31.56M | 24.43M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 7.34M | 7.2M | 7.22M | 8.01M | 6.45M | 6.69M | 7.42M | 6.45M | 6.9M | 6.72M | 5.99M | 4.98M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 12.03M | 12.34M | 12.04M | 46.46M | 13.34M | 22.64M | 24.78M | 26.76M | 27.02M | 21.64M | 25.57M | 19.45M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | -200K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -19.37M | -19.54M | -19.27M | -54.47M | -19.79M | -29.33M | -32.52M | -33.22M | -33.92M | -28.36M | -31.56M | -24.43M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 2.11% | 33.4% | 40.76% | -63.97% | 41.66% | -3.41% | -3.03% | -35.96% | -56.47% | -50% | -51.91% | -35.47% |
| EBITDA | -19.17M | -19.34M | -19.01M | -54.18M | -19.49M | -29.02M | -32.2M | -32.89M | -33.59M | -28.09M | -31.26M | -24.18M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 1.67% | 33.38% | 40.96% | -64.7% | 41.98% | -3.31% | -3.01% | -36.04% | -56.85% | -50.76% | -52.38% | -35.81% |
| D&A (Non-Cash Add-back) | 205K | 200K | 252K | 287K | 297K | 305K | 314K | 323K | 325K | 269K | 299K | 252K |
| EBIT | -17.58M | -17.64M | -19.27M | -54.47M | -19.79M | -29.33M | -32.52M | -33.22M | -33.92M | -28.36M | -31.56M | -24.43M |
| Net Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 1.79M | 1.89M | 2.1M | 1.22M | 1.36M | 1.67M | 2M | 2.34M | 2.55M | 3.08M | 2.29M | 1.48M |
| Pretax Income | -17.58M | -17.64M | -17.16M | -53.25M | -18.43M | -27.66M | -30.52M | -30.88M | -31.37M | -25.28M | -29.27M | -22.95M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -17.58M | -17.64M | -17.16M | -53.25M | -18.43M | -27.66M | -30.52M | -30.88M | -31.37M | -25.28M | -29.27M | -22.95M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 4.62% | 36.22% | 43.76% | -72.46% | 41.25% | -9.43% | -4.27% | -34.53% | -47.73% | -31.78% | -43.01% | -28.01% |
| Net Income (Continuing) | -17.58M | -17.64M | -17.16M | -53.25M | -18.43M | -27.66M | -30.52M | -30.88M | -31.37M | -25.28M | -29.27M | -22.95M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.65 | -0.65 | -0.64 | -9.12 | -3.79 | -5.69 | -6.32 | -6.44 | -6.54 | -5.28 | -6.12 | -5.14 |
| EPS Growth % | 82.85% | 88.5% | 89.92% | -41.79% | 42.07% | -7.91% | -3.34% | -25.09% | -29.73% | -7.06% | -10.48% | -5.95% |
| EPS (Basic) | -0.65 | -0.65 | -0.64 | -9.12 | -3.79 | -5.69 | -6.32 | -6.44 | -6.54 | -5.28 | -6.12 | -5.14 |
| Diluted Shares Outstanding | 26.96M | 26.95M | 26.93M | 5.84M | 4.86M | 4.86M | 4.83M | 4.8M | 4.79M | 4.79M | 4.79M | 4.46M |
| Basic Shares Outstanding | 26.96M | 26.95M | 26.93M | 5.84M | 4.86M | 4.86M | 4.83M | 4.8M | 4.79M | 4.79M | 4.79M | 4.46M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |